<DOC>
	<DOCNO>NCT02288156</DOCNO>
	<brief_summary>Chronic rhinitis affect 200 million people worldwide . Its prevalence estimate high 30 % Western population . Rhinitis define symptomatic inflammation inner line nose characterize follow symptom : rhinorrhea , nasal blockage , nasal itch and/or sneezing . The cut-off point define rhinitis chronic rhinitis consider persisting symptom twelve week Chronic rhinitis divide three major subgroup ; base knowledge major etiological factor : infectious rhinitis , allergic rhinitis non-allergic , non-infectious rhinitis , literature also refer nonallergic rhinitis . Non-inferiority efficacy two novel treatment regime i.e . capsaicin nasal spray 0,01mM ( 2puffs/nostril/day ) 4 week capsaicin nasal spray 0,001mM ( 2puffs/nostril/day ) 4 week compare current treatment capsaicin nasal spray 0,1mM ( 5/day administer single day ) regard change baseline VAS major nasal symptom week 4 . ( Estimated placebo effect 25 % . )</brief_summary>
	<brief_title>Elaboration Patient-friendly Treatment Strategy With Capsaicin Nasal Spray Patients With Idiopathic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>idiopathic rhinitis patient least 2 persistent ( &gt; 12w ) rhinological symptom ( nasal discharge , sneeze , nasal congestion ) average least 1 h per day , idiopathic rhinitis patient total nasal symptom score ( TNS ) 5 visual analogue scale ( VAS ) . Age &gt; 18 &lt; 65 year . Written informed consent . Willingness adhere visit schedule . Adequate contraceptive precaution female patient childbearing potential . Patients concomitant allergic rhinitis , demonstrate positive skin prick test ( Hal reagent ) and/or immunoglobins E blood . * Patients structural abnormality : nasal polyp , severe septal deviation ( septum reach concha inferior lateral nasal wall ) , septal perforation , hypertrophy inferior turbinate . Patients local allergic rhinitis ( LAR ) entopy . Systemic steroid treatment le 4 week inclusion study , nasal steroid spray le 4 week inclusion , oral leukotriene antagonist longacting antihistamine less 2 week inclusion . Inability patient stop take medication affect nasal function like ÃŸblockers . History prolong use abuse decongestant nasal spray like xylometazoline spray and/or use abuse decongestive oral medication . Evidence infectious rhinitis/rhinosinusitis common cold within 4 week prior inclusion . Pregnancy lactation . ** Any disorder might compromise ability patient give truly informed consent participation study . Enrollment investigational drug trial ( ) receive investigational agent ( ) medical condition . Contraindications use local anesthesia ( cocaine 5 % ) . Smoking occupational exposure irritant ( like hypochlorite , persulfates , isocyanate ) . Nasal malignancy severe comorbidity like granulomatosis vasculitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>